世界の帯状疱疹治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Herpes Zoster Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12332 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、帯状疱疹治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。帯状疱疹治療の種類別市場規模（経口、局所、その他）、用途別市場規模（病院、クリニック、在宅ケア施設）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・帯状疱疹治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Novartis、Merck、GlaxoSmithKline、Abbott Laboratories、Astellas Pharma、Bausch Health Companies、Teva Pharmaceutical、Foamix Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、局所、その他 ・用途別分析2016年-2026年：病院、クリニック、在宅ケア施設 ・帯状疱疹治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・帯状疱疹治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・帯状疱疹治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・帯状疱疹治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・帯状疱疹治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Herpes Zoster Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Herpes Zoster Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Herpes Zoster Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Herpes Zoster Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Topical
Others

Market segment by Application, can be divided into
Hospitals
Clinics
Home Care Settings

Market segment by players, this report covers
Roche
Novartis
Merck
GlaxoSmithKline
Abbott Laboratories
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical
Foamix Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Herpes Zoster Treatment
1.2 Classification of Herpes Zoster Treatment by Type
1.2.1 Overview: Global Herpes Zoster Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Herpes Zoster Treatment Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Topical
1.2.5 Others
1.3 Global Herpes Zoster Treatment Market by Application
1.3.1 Overview: Global Herpes Zoster Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.4 Global Herpes Zoster Treatment Market Size & Forecast
1.5 Global Herpes Zoster Treatment Market Size and Forecast by Region
1.5.1 Global Herpes Zoster Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Herpes Zoster Treatment Market Size by Region, (2016-2021)
1.5.3 North America Herpes Zoster Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Herpes Zoster Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Herpes Zoster Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Herpes Zoster Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Herpes Zoster Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Herpes Zoster Treatment Market Drivers
1.6.2 Herpes Zoster Treatment Market Restraints
1.6.3 Herpes Zoster Treatment Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Herpes Zoster Treatment Product and Solutions
2.1.4 Roche Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Herpes Zoster Treatment Product and Solutions
2.2.4 Novartis Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Herpes Zoster Treatment Product and Solutions
2.3.4 Merck Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Herpes Zoster Treatment Product and Solutions
2.4.4 GlaxoSmithKline Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Herpes Zoster Treatment Product and Solutions
2.5.4 Abbott Laboratories Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abbott Laboratories Recent Developments and Future Plans
2.6 Astellas Pharma
2.6.1 Astellas Pharma Details
2.6.2 Astellas Pharma Major Business
2.6.3 Astellas Pharma Herpes Zoster Treatment Product and Solutions
2.6.4 Astellas Pharma Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Astellas Pharma Recent Developments and Future Plans
2.7 Bausch Health Companies
2.7.1 Bausch Health Companies Details
2.7.2 Bausch Health Companies Major Business
2.7.3 Bausch Health Companies Herpes Zoster Treatment Product and Solutions
2.7.4 Bausch Health Companies Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bausch Health Companies Recent Developments and Future Plans
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Herpes Zoster Treatment Product and Solutions
2.8.4 Teva Pharmaceutical Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
2.9 Foamix Pharmaceuticals
2.9.1 Foamix Pharmaceuticals Details
2.9.2 Foamix Pharmaceuticals Major Business
2.9.3 Foamix Pharmaceuticals Herpes Zoster Treatment Product and Solutions
2.9.4 Foamix Pharmaceuticals Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Foamix Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Herpes Zoster Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Herpes Zoster Treatment Players Market Share
3.2.2 Top 10 Herpes Zoster Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Herpes Zoster Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Herpes Zoster Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Herpes Zoster Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Herpes Zoster Treatment Revenue Market Share by Application (2016-2021)
5.2 Herpes Zoster Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Herpes Zoster Treatment Revenue by Type (2016-2026)
6.2 North America Herpes Zoster Treatment Revenue by Application (2016-2026)
6.3 North America Herpes Zoster Treatment Market Size by Country
6.3.1 North America Herpes Zoster Treatment Revenue by Country (2016-2026)
6.3.2 United States Herpes Zoster Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Herpes Zoster Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Herpes Zoster Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Herpes Zoster Treatment Revenue by Type (2016-2026)
7.2 Europe Herpes Zoster Treatment Revenue by Application (2016-2026)
7.3 Europe Herpes Zoster Treatment Market Size by Country
7.3.1 Europe Herpes Zoster Treatment Revenue by Country (2016-2026)
7.3.2 Germany Herpes Zoster Treatment Market Size and Forecast (2016-2026)
7.3.3 France Herpes Zoster Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Herpes Zoster Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Herpes Zoster Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Herpes Zoster Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Herpes Zoster Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Herpes Zoster Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Herpes Zoster Treatment Market Size by Region
8.3.1 Asia-Pacific Herpes Zoster Treatment Revenue by Region (2016-2026)
8.3.2 China Herpes Zoster Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Herpes Zoster Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Herpes Zoster Treatment Market Size and Forecast (2016-2026)
8.3.5 India Herpes Zoster Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Herpes Zoster Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Herpes Zoster Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Herpes Zoster Treatment Revenue by Type (2016-2026)
9.2 South America Herpes Zoster Treatment Revenue by Application (2016-2026)
9.3 South America Herpes Zoster Treatment Market Size by Country
9.3.1 South America Herpes Zoster Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Herpes Zoster Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Herpes Zoster Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Herpes Zoster Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Herpes Zoster Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Herpes Zoster Treatment Market Size by Country
10.3.1 Middle East & Africa Herpes Zoster Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Herpes Zoster Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Herpes Zoster Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Herpes Zoster Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Herpes Zoster Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Herpes Zoster Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Herpes Zoster Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Herpes Zoster Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Herpes Zoster Treatment Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Herpes Zoster Treatment Product and Solutions
Table 9. Roche Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Herpes Zoster Treatment Product and Solutions
Table 13. Novartis Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Herpes Zoster Treatment Product and Solutions
Table 17. Merck Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Herpes Zoster Treatment Product and Solutions
Table 21. GlaxoSmithKline Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Laboratories Major Business
Table 24. Abbott Laboratories Herpes Zoster Treatment Product and Solutions
Table 25. Abbott Laboratories Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Astellas Pharma Major Business
Table 28. Astellas Pharma Herpes Zoster Treatment Product and Solutions
Table 29. Astellas Pharma Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bausch Health Companies Corporate Information, Head Office, and Major Competitors
Table 31. Bausch Health Companies Major Business
Table 32. Bausch Health Companies Herpes Zoster Treatment Product and Solutions
Table 33. Bausch Health Companies Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Teva Pharmaceutical Major Business
Table 36. Teva Pharmaceutical Herpes Zoster Treatment Product and Solutions
Table 37. Teva Pharmaceutical Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Foamix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Foamix Pharmaceuticals Major Business
Table 40. Foamix Pharmaceuticals Herpes Zoster Treatment Product and Solutions
Table 41. Foamix Pharmaceuticals Herpes Zoster Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Herpes Zoster Treatment Revenue (USD Million) by Players (2019-2021)
Table 43. Global Herpes Zoster Treatment Revenue Share by Players (2019-2021)
Table 44. Breakdown of Herpes Zoster Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Herpes Zoster Treatment Players Head Office, Products and Services Provided
Table 46. Herpes Zoster Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Herpes Zoster Treatment New Entrants and Expansion Plans
Table 48. Global Herpes Zoster Treatment Revenue (USD Million) by Type (2016-2021)
Table 49. Global Herpes Zoster Treatment Revenue Share by Type (2016-2021)
Table 50. Global Herpes Zoster Treatment Revenue Forecast by Type (2021-2026)
Table 51. Global Herpes Zoster Treatment Revenue by Application (2016-2021)
Table 52. Global Herpes Zoster Treatment Revenue Forecast by Application (2021-2026)
Table 53. North America Herpes Zoster Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Herpes Zoster Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Herpes Zoster Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Herpes Zoster Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Herpes Zoster Treatment Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Herpes Zoster Treatment Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Herpes Zoster Treatment Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Herpes Zoster Treatment Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Herpes Zoster Treatment Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Herpes Zoster Treatment Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Herpes Zoster Treatment Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Herpes Zoster Treatment Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Herpes Zoster Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Herpes Zoster Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Herpes Zoster Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Herpes Zoster Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Herpes Zoster Treatment Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Herpes Zoster Treatment Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Herpes Zoster Treatment Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Herpes Zoster Treatment Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Herpes Zoster Treatment Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Herpes Zoster Treatment Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Herpes Zoster Treatment Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Herpes Zoster Treatment Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Herpes Zoster Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Herpes Zoster Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Herpes Zoster Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Herpes Zoster Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Herpes Zoster Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Herpes Zoster Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Herpes Zoster Treatment Picture
Figure 2. Global Herpes Zoster Treatment Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Topical
Figure 5. Others
Figure 6. Herpes Zoster Treatment Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Home Care Settings Picture
Figure 10. Global Herpes Zoster Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Herpes Zoster Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Herpes Zoster Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Herpes Zoster Treatment Revenue Market Share by Region in 2020
Figure 14. North America Herpes Zoster Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Herpes Zoster Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Herpes Zoster Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Herpes Zoster Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Herpes Zoster Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Herpes Zoster Treatment Market Drivers
Figure 20. Herpes Zoster Treatment Market Restraints
Figure 21. Herpes Zoster Treatment Market Trends
Figure 22. Roche Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. Abbott Laboratories Recent Developments and Future Plans
Figure 27. Astellas Pharma Recent Developments and Future Plans
Figure 28. Bausch Health Companies Recent Developments and Future Plans
Figure 29. Teva Pharmaceutical Recent Developments and Future Plans
Figure 30. Foamix Pharmaceuticals Recent Developments and Future Plans
Figure 31. Global Herpes Zoster Treatment Revenue Share by Players in 2020
Figure 32. Herpes Zoster Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Herpes Zoster Treatment Revenue Market Share in 2020
Figure 34. Global Top 10 Players Herpes Zoster Treatment Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Herpes Zoster Treatment Revenue Share by Type in 2020
Figure 37. Global Herpes Zoster Treatment Market Share Forecast by Type (2021-2026)
Figure 38. Global Herpes Zoster Treatment Revenue Share by Application in 2020
Figure 39. Global Herpes Zoster Treatment Market Share Forecast by Application (2021-2026)
Figure 40. North America Herpes Zoster Treatment Sales Market Share by Type (2016-2026)
Figure 41. North America Herpes Zoster Treatment Sales Market Share by Application (2016-2026)
Figure 42. North America Herpes Zoster Treatment Revenue Market Share by Country (2016-2026)
Figure 43. United States Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Herpes Zoster Treatment Sales Market Share by Type (2016-2026)
Figure 47. Europe Herpes Zoster Treatment Sales Market Share by Application (2016-2026)
Figure 48. Europe Herpes Zoster Treatment Revenue Market Share by Country (2016-2026)
Figure 49. Germany Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Herpes Zoster Treatment Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Herpes Zoster Treatment Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Herpes Zoster Treatment Revenue Market Share by Region (2016-2026)
Figure 57. China Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Herpes Zoster Treatment Sales Market Share by Type (2016-2026)
Figure 64. South America Herpes Zoster Treatment Sales Market Share by Application (2016-2026)
Figure 65. South America Herpes Zoster Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Herpes Zoster Treatment Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Herpes Zoster Treatment Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Herpes Zoster Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Herpes Zoster Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---